Understanding Assessing Formulation Stability In Early Development Phases
If you are looking for information about Assessing Formulation Stability In Early Development Phases, you have come to the right place. This video reviews the importance of the
Key Takeaways about Assessing Formulation Stability In Early Development Phases
- Moderated by Jennifer Chu, Ph.D., FreeThink Technologies Speaker: Maria Krisch, Ph.D., FreeThink Technologies What you will ...
- Physiologically based pharmacokinetic (PBPK) modeling is a core element of the
- Webinar: Developability
- http://gene.com/making - Medicines won't work unless they are stable and can be properly administered. We need to be clever to ...
- Stability
Detailed Analysis of Assessing Formulation Stability In Early Development Phases
Description. Rely on our speed-to-study™ solution to initiate Brent Moody, Principal Scientist at Catalent Pharma Solutions, discusses the data-driven approach for selecting the most ...
ICH Q3E Guideline is changing how the pharmaceutical industry approaches Extractables & Leachables (E&L) — especially for ...
We hope this detailed breakdown of Assessing Formulation Stability In Early Development Phases was helpful.